Upgrade to SI Premium - Free Trial

Roche (RHHBY)

51.70 +0.13 (0.25%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection June 4, 2026 11:34 AM - PR NewsWire U.S. Food and Drug Administration Approves FoundationOne®CDx as a Companion Diagnostic for Itovebi™ (inavolisib) to Identify Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer wit June 2, 2026 7:00 AM - BizWire FDA Accepts New Drug Application for Genentech’s Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting June 2, 2026 1:05 AM - BizWire Genentech to present obesity drug data at diabetes conference June 1, 2026 1:01 AM - StreetInsider Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association’s 2026 Scientific Sessions June 1, 2026 1:01 AM - BizWire Flatiron Health Brings 25+ Research Acceptances and Next-Generation Capabilities to ASCO 2026 May 21, 2026 5:00 PM - BizWire New Research Confirms Data Quality as the Defining Priority Across the Real-World Evidence Landscape May 20, 2026 9:00 AM - BizWire Flatiron Health Launches Flatiron Telescope, a New AI Platform Delivering Oncology Insights in Minutes May 19, 2026 9:00 AM - BizWire Genentech presents new giredestrant breast cancer data at ASCO 2026 May 19, 2026 1:05 AM - StreetInsider Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant's Potential to Transform the Treatment Paradigm in Early Breast Cancer May 19, 2026 1:05 AM - BizWire FDA approves Genentech's Tecentriq for bladder cancer with ctDNA guidance May 15, 2026 12:45 PM - StreetInsider FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment May 15, 2026 12:45 PM - BizWire Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026 April 30, 2026 1:00 AM - BizWire Roche Holding (ROG:SW) (RHHBY) PT Lowered to CHF376 at UBS April 27, 2026 4:43 AM - StreetInsider Genentech Partners With Comedy Icon Damon Wayans and diaTribe to Address Diabetes-Related Vision Loss With ‘All Eyes on DME’ Campaign April 24, 2026 8:00 AM - BizWire Morgan Stanley Upgrades Roche Holding (ROG:SW) (RHHBY) to Equalweight April 24, 2026 2:49 AM - StreetInsider Morgan Stanley Upgrades Roche (RHHBY) to Equalweight April 24, 2026 2:47 AM - StreetInsider Flatiron Health Announces 18 Research Acceptances Featuring Flatiron's Real-World Data to Be Presented at ISPOR 2026 April 22, 2026 9:00 AM - BizWire Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition April 22, 2026 8:30 AM - Globe NewsWire Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS April 21, 2026 7:15 PM - BizWire Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD April 21, 2026 11:45 AM - BizWire FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus April 21, 2026 1:00 AM - BizWire Flatiron Health Publishes First Peer-Reviewed Validation Framework for AI-Extracted Real-World Oncology Data in Journal of Clinical Oncology April 20, 2026 9:00 AM - BizWire Foundation Medicine to Strengthen Monitoring Portfolio with SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease (MRD) Platform April 16, 2026 7:00 AM - BizWire C4 Therapeutics expands Roche partnership with new DAC collaboration April 9, 2026 6:59 AM - StreetInsider C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs) April 9, 2026 6:59 AM - Globe NewsWire Roche (RHHBY) PT Lowered to $46 at Morgan Stanley April 7, 2026 10:28 AM - StreetInsider Argus Upgrades Roche (RHHBY) to Buy April 6, 2026 8:48 AM - StreetInsider Roche gets FDA clearance for two new laboratory analytical units March 30, 2026 9:01 AM - StreetInsider Roche receives FDA 510(k) clearance for cobas® c703 and cobas® ISE neo, next-generation analytical units enhancing efficiency and capability for laboratories March 30, 2026 9:01 AM - PR NewsWire /C O R R E C T I O N -- Roche/ March 24, 2026 3:27 PM - PR NewsWire Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE markets March 24, 2026 2:00 AM - PR NewsWire Cantor Fitzgerald: 'We now expect apitegromab to have near complete market share' March 19, 2026 2:11 PM - StreetInsider Roche expands mass spectrometry menu to include steroid assays receiving CLIA 'moderate complexity' designation March 18, 2026 9:00 AM - PR NewsWire Roche Holding (ROG:SW) (RHHBY) PT Lowered to CHF365 at HSBC March 17, 2026 3:42 AM - StreetInsider Roche gets CE mark for blood test detecting Alzheimer's gene variant March 16, 2026 2:00 AM - StreetInsider Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease March 16, 2026 2:00 AM - PR NewsWire Roche Holding (ROG:SW) (RHHBY) PT Lowered to CHF325 at JPMorgan March 12, 2026 4:05 AM - StreetInsider Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer March 9, 2026 2:10 AM - BizWire Full Article List